Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Efficacy benefits of fingolimod 0.5 mg once daily in patients previously treated with glatiramer acetate: Pooled analysis of the phase 3, placebo-controlled FREEDOMS and FREEDOMS II studies in relapsing multiple sclerosis
Multiple Sclerosis
(-)
193
Authors/Disclosures
Douglas R. Jeffery, MD, PhD (Lake Norman Neurology At Piedmont Health Care)
PRESENTER 		No disclosure on file
Ernst-Wilhelm Radue, MD (Medical Image Analysis Center) Dr. Radue has nothing to disclose.
Goeril Karlsson, PhD Dr. Karlsson has received personal compensation for serving as an employee of Novartis.
No disclosure on file
Sebastian F. Von Rosenstiel, MD, PhD (Takeda) Dr. Von Rosenstiel has received personal compensation for serving as an employee of Takeda. Dr. Von Rosenstiel has stock in Takeda.
Ludwig Kappos, MD, FÂ鶹´«Ã½Ó³»­ (RC2NB, University Hospital Basel) Dr. Kappos has nothing to disclose.
Jason S. Mackey, MD Dr. Mackey has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for legal firms. The institution of Dr. Mackey has received research support from PCORI.